<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
PTGX
Protagonist Therapeutics
$
()


  • Protagonist Therapeutics participates in a conference call with JPMorgan

    9/25/2024 - 13:45pm
  • Protagonist Therapeutics participates in a conference call with JPMorgan

    9/25/2024 - 11:36am
  • Walmart upgraded, Starbucks downgraded: Wall Street's top analyst calls

    9/24/2024 - 09:32am
  • Protagonist Therapeutics initiated with bullish view at TD Cowen, here's why

    9/24/2024 - 05:42am
  • Protagonist Therapeutics price target raised by $10 at H.C. Wainwright, here's why

    9/12/2024 - 06:04am
  • Protagonist Therapeutics initiated with bullish view at Truist, here's why

    9/9/2024 - 06:23am
  • Protagonist Therapeutics price target lowered to $43 from $45 at JMP Securities

    8/7/2024 - 06:44am
  • Protagonist Therapeutics price target raised by $2 at H.C. Wainwright, here's why

    8/7/2024 - 06:10am
  • Protagonist Therapeutics sees cash runway through end of 2027

    8/6/2024 - 07:55am
  • Protagonist Therapeutics reports Q2 EPS (50c), consensus (60c)

    8/6/2024 - 07:54am
  • Protagonist Therapeutics announces publication of clinical data on JNJ-2113

    8/1/2024 - 08:20am
  • Protagonist Therapeutics appoints Newman Yeilding as chief scientific advisor

    7/31/2024 - 09:19am
  • Protagonist Therapeutics price target raised by $10 at BTIG, here's why

    7/24/2024 - 07:17am
  • Protagonist Therapeutics to replace Encore Wire in S&P 600 at open on 7/3

    7/3/2024 - 04:55am
  • Fly Intel: After-Hours Movers

    6/27/2024 - 19:37pm
dynamic_feed Breaking News